
Bart Filius
Fortuna: 246 297 $ al 31/05/2026

Fortuna: 246 297 $ al 31/05/2026
Actualmente, Bart Filius es Presidente y Director de Operaciones de Galapagos NV. El Sr. Filius también forma parte del consejo de Galapagos Biotech Ltd. y de ProQR Therapeutics NV. En su anterior carrera, el Sr. Filius ocupó el cargo de Director Financiero y Director Nacional de Sanofi-Aventis Netherlands BV y Director Financiero de Sanofi European Treasury Center SA. El Sr. Filius se licenció en la Nyenrode Business Universiteit y obtuvo un MBA en el INSEAD.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IDORSIA LTD. 0,02 % | 31/12/2024 | 43.091 ( 0,02 % ) | 246 297 $ | 31/05/2026 |
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Director/Miembro de la Junta | 21/05/2019 |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services | Director/Miembro de la Junta | - |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| IDORSIA LTD | Director/Miembro de la Junta | 06/05/2026 |
| LAKEFRONT BIOTHERAPEUTICS NV | Presidente | 30/06/2023 |
Sanofi European Treasury Center SA
Sanofi European Treasury Center SA Financial ConglomeratesFinance Provides financial services | Director Financiero/CFO | 01/12/2014 |
sanofi-aventis Netherlands BV | Director Financiero/CFO | 01/03/2012 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Galapagos NV
Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Nyenrode Business Universiteit
Nyenrode Business Universiteit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
sanofi-aventis Netherlands BV | |
Sanofi European Treasury Center SA
Sanofi European Treasury Center SA Financial ConglomeratesFinance Provides financial services | Finance |
ProQR Therapeutics NV
ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Idorsia Ltd.
Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.